Study of a Care Support Program to Reduce Anxiety After an Acute Leukemia Diagnosis

What this Trial Is About

This research aims to evaluate the impact on anxiety in patients diagnosed with acute leukemia AL by comparing those who receive a period of care support following their diagnosis announcement with those who do not. The study focuses on how this specialized support might affect patients anxiety levels and quality of life during a critical time after diagnosis. Participants are adults aged 26 to 80 years who are newly diagnosed and hospitalized for acute leukemia. Participants will be randomly assigned to one of two groups. One group will receive usual care without additional support, while the other group will have dedicated time with a nurse specialized in delivering the diagnosis and providing care support soon after the diagnosis announcement. Anxiety and quality of life will be assessed at multiple time points, including at diagnosis, shortly after the care support period, and two months after ICU admission. Patients in the care support group will also complete an evaluation of the support received, and all participants will fill out satisfaction questionnaires about their care. Throughout the study, patients will complete anxiety and quality of life questionnaires at specified times to measure changes and effects of the care support. The primary outcome measured is anxiety improvement seven days after the diagnosis announcement. Both groups will be monitored within their usual care setting, with assessments conducted shortly after diagnosis and following ICU admission. The study lasts through these scheduled assessments to understand the psychological effects of care support during this period.

Benefits of Formalized Care Support Program Following Acute Leukemia Diagnosis